cd chart - media.beckman.com · cd49e integrin a5, vla-5 achain p act p p p p p p p p l cd49f...
TRANSCRIPT
![Page 1: CD CHART - media.beckman.com · CD49e integrin a5, VLA-5 achain p Act p p p p p p p p l CD49f integrin a6, VLA-6 achain, platelet gpIc p p p p p p CD50 ICAM-3 (intercellular adhesion](https://reader036.vdocuments.us/reader036/viewer/2022081515/5be7854809d3f2db738c80c3/html5/thumbnails/1.jpg)
CD CHART
CD N° Alternative NameT
Cells
B C
ells
Gra
nu
locy
tes
NK
Cells
Macr
op
hag
es/
Mo
no
cyte
s
Pla
tele
ts
Ery
thro
cyte
s
Ste
m C
ells
Den
dri
tic
Cells
En
do
thelial C
ells
Ep
ith
elial C
ells
Beck
man
Co
ult
er
Clo
ne
CD1a T6, R4, HTA1 Act p n n p n n S lCD1b R1 Act p n n p n n S
CD1c R7, M241 Act S n n p n n S lCD1d R3 Act S n n Low n n S Intest
CD1e R2 n n n n S
CD2 T11; Tp50; sheep red blood cell (SRBC) receptor; LFA-2 p S n p n n lCD3 T3, CD3 complex p n n n n n n n n n lCD3d CD3δ p
CD3e CD3ε p
CD3g CD3γ p
CD4 T4 S n p n p n n n n n lCD5 T1, Tp67 p S / Low n n n n n lCD6 T12, Tp120 p S n n n n lCD7 gp40, Tp41 S n n S n n n p lCD8 T8, LeuT S n n S n n n n n n lCD8b - S n n n n n n n n n lCD9 p24, MRP-1, MIC3, Tspan-29 Act Act Low p p n p p lCD10 CALLA, neutral endopeptidase (NEP), gp100 n n p n n n n p lCD11a aL integrin chain; LFA-1, gp180/95 p p Low p p n n lCD11b aM integrin chain, Mac-1, Mo1, CR3, a-chain of C3biR S S p p p n Folli n lCD11c aX integrin chain, p150,95, CR4 S / Low S / Low Low p p n p n lCD11d integrin aD subunit p
CDw12 p90-120 n n p p p p n p
CD13 Aminopeptidase N, APN, (EC 3.4.11.2), gp150, ANPEP p n p n p n n p p p lCD14 LPS receptor n Low Low n p lCD15 Lewis X (Le-X), 3-fucosyl-N-acetyl-lactosamine ( 3-FAL) S / Act S / Act p n p n n p S / Act n S lCD16 CD16a, FcγRIIIa S / Act n p p p n n p lCD16b FcγRIIIb p n n lCD17 LacCer, lactosylceramide p S p n p p n Tons p p
CD18 b2 integrin chain p p p p p p n p n lCD19 B4 , Bgp95 n p n n n n n p Folli n n lCD20 B1, Bgp35 Low p n n n n n n Folli n n lCD21 CR2, EBV-R, C3d-receptor, gp140 S p n n n n n p Folli n Low lCD22 BL-CAM, Siglec2, Bgp135 n p n n n n n p n n n lCD23 FcεRII, Blast-2, low affinity IgE receptor, IGEBF, gp50-45 p Act p n p p n Folli n p lCD24 BA-1, HSA (Heat stable antigen homologue) n p p n n n n n n n p lCD25 IL-2Ra, Tac antigen S / Act Act n p p n n n n n n lCD26 DPPIV ectoenzyme, ADA-binding protein, Tp103 p p n p p n n n n n p lCD27 T14, S152, Tp55, TNFRSF7 p Act n p n n n n n n n lCD28 Tp44 S n n n n n n n n n n lCD29 platelet GPIIa, VLA-bchain, Integrin b1 chain p p Low p p p p p p p lCD30 Ki-1 antigen, Ber-H2 antigen, TNFRSF8 Act Act n Act p n n p p n lCD31 PECAM-1, platelet GPIIa’, endocam S S p p p p n p lCD32 FCγRII, FCGR2A, gp40 S / Low p p n p p n n lCD32b FCGR2B, IGFR2 S p p n p p n p
CD32c FCGR2C, IGFR2 p p p
CD33 My9, gp67, p67, Siglec3 S / Act n Low n p n n p p n n lCD34 gp105-120, My10 n n n n n n n p n p lCD35 CR1, C3b/C4b receptor, Immune Adherence Receptor S p p S S n p Folli lCD36 platelet GPIV, GPIIIb, OKM5-antigen, PASIV n n n n p p p p p p n lCD37 gp52-40, Tspan-26 Low p Low n Low n n lCD38 T10, gp45, ADP-ribosyl cyclase Act p n p p p p lCD39 gp80, E-ATPDase, NTPDase-1 S / Act Act p p n p p p lCD40 Bp50, TNF receptor 5 S p n n p n S Folli p S lCD41 platelet GPIIb, aIIb integrin, HPA3 n n n n n p n p n n n lCD42a platelet GPIX, gp9 n n n n n p n p n n n lCD42b platelet GPIb-a, Glycocalicin n n n n n p n p n n n lCD42c platelet GPIb-b n n n n n p n p n n n
CD42d platelet GPV n n n n n p n p n n n
CD43 leukosialin, sialophorin, gpL115, gp95 p Act p p S Low n p lCD44 Pgp-1; gp80-95, Hermes antigen, ECMR-III, HUTCH-I, H-CAM p p p p p n p p p lCD44R CD44v1-10, CD44 variant Act Act Act p p
CD45 LCA, T200, B220, EC 3.1.3.4 p p p p p n n p p n n lCD45RA restricted T200 S p n p p n n p p n n lCD45RB restricted T200 S p Low p p n n p p n n
CD45RC restricted T200 S p n p p n n p p n n
CD45RO restricted T200 S p p p p n n p p n n lCD46 MCP (membrane cofactor protein) p p p p p p n p p
CD47 IAP, Rh-associated protein, OA3, gp42, MEM-133, CDw149 p p p p p p p p p
CD48 Blast-1, HuLym3, p p n p p n n p lCD49a integrin a1, VLA-1 achain Act n n p p n n p n
CD49b integrin a2, VLA-2 achain, platelet gpIa Act p n p p p n p p p lCD49c integrin a3, VLA-3 achain p p n p n p p
CD49d integrin a4, VLA-4 achain p p n p p n n p p p lCD49e integrin a5, VLA-5 achain p Act p p p p p p p p lCD49f integrin a6, VLA-6 achain, platelet gpIc p p p p p p
CD50 ICAM-3 (intercellular adhesion molecule 3) p p p p p n n p p n lCD51 integrin av, VNR achain S n Act Low p
CD52 Campath-1, HE5 p p p p n n S p lCD53 MEM-53, tetraspanin-25, Tspan-25 p p p p p n n p p n
CD54 ICAM-1 (intercellular adhesion molecule 1) Act Act Low Low Low lCD55 DAF (Decay accelerating factor) p p p Low p p p p p p lCD56 NCAM (neural cell adhesion molecule), NKH1 S p lCD57 HNK1 S / Act S lCD58 LFA-3 (lymphocyte function associated antigen-3) p p p p p p p p p lCD59 MACIF, MIRL, P-18, HRF20, 1F-5Ag, H19, protectin p p p p p lCD60a GD3 S Low p p p n
CD60b 9-O-acetyl-GD3 S Act
CD60c 7-O-acetyl-GD3 S
CD61 GPIIIa, b3 integrin p p p lCD62E E-selectin, ELAM-1, LECAM-2 Act
CD62L L-selectin, LAM-1, LECAM-1 p p p S p lCD62P P-selectin, GMP140, PADGEM Act Act lCD63 LIMP, gp-55, Pltgp40, LAMP-3, granulophysin p S / Low Low p p Act n Act lCD64 FcγRI Act S lCD64a FCRI, IGFR1 n n p n p n n p p n n
CD65 Ceramide-dodecasaccharide 4c n n p p lCD65s VIM2, sialylated-CD65 n n p n p n n n
CD66a BGP, NCA-160 Act n p p n n n p
CD66b CGM6, NCA-95, previously CD67 n n p n n n n lCD66c NCA, NCA50/90, KOR-SA3544 n n p n n n n p lCD66d CGM1 n n p n n n n
CD66e CEA (carcinoembryonic antigen) n n n n n n p
CD66f PSG (pregnancy-specific glycoprotein), Sp-1 n n n n n n p
CD68 gp110 Act p p p n n S p
CD69 AIM (activation-induced molecule), MLR3, EA1 Act p p p p p lCD70 CD27 ligand, KI-24 antigen Act Act n Act n n n n n n n
CD71 T9, transferrin receptor n n n n p n p lCD72 Ly-19.2, Ly32.2 p n n p n n p Folli
CD73 Ecto-5'-nucleotidase S S n n n n n p Folli p p
CD74 MHC class II invariant chain, class II specific chaperone Act p p p Act Act
CD75 lactosamines S S n n p n p n n S
CD75s sialylated lactosamines S S p n p n p n S S
CD77 Gb3, BLA, CTH, Pk blood group antigen n p n n n n n n p p lCD79a mb-1 gene product, IGA, Ig-a n p n n n n n n n n lCD79b B29 gene product, IGB, Ig-b n p n n n n n n n n lCD80 BB1, B7-1 Act Act n n p n n n p n n lCD81 TAPA-1, M38 p p Low p p n n p p p p lCD82 R2, IA4, 4F9, C33 Low Low p p p p n p p p
CD83 HB15 Act Act n n n n n n p n n lCD84 p75, GR6, SLAMF5 S p n p S p n n p n n
CD85a ILT5/LIR3, HL9 S n p Low p n n p Low n n
CD85b ILT8, LILRB6 S p S p p
CD85c LIR8 p p
CD85d ILT4/LIR2, MIR10 Low S lCD85e ILT6/LIR4, HM31, HM43 p p p p
CD85f ILT11 p
CD85g ILT7 p p p
CD85h ILT1/LIR7
CD85i LIR6a, LILRA1 p p
CD85j ILT2/LIR1, MIR7, LILRB1 S Low S p p lCD85k ILT3/LIR5, HM18 p p lCD85l ILT9
CD85m ILT10, LILRA5, LILRP2
CD86 B7.2, B70 n S n n p n n n p p n lCD87 uPAR (urokinase plasminogen activator receptor) S / Act n Low p p n n n S p n
CD88 C5a-R (complement 5a receptor) n n p n p n n n p p p
CD89 FcaR, IgA receptor, IgA Fc receptor n n p n p n n p n n
CD90 Thy-1 S n n n n n n p Act n lCD91 a2M-R, LRP, LDL receptor n n n n p n n n p
CD92 VIM15, p70, CHTL1 Low Low p n p n n Low Low
CD93 C1qR1, GR11, C1qRP n n p p n n n p n
CD94 Kp43 S n n p n n n n n lCD95 Fas, APO-1, TNFRSF6, APT1 S S p S p n n lCD96 TACTILE Act Low n Act n n n
CD97 BL-KDD/F12 Act Act p p p n n p
CD98 4F2, FRP-1 p p p p p p n p p
CD N° Alternative Name
T C
ells
B C
ells
Gra
nu
locy
tes
NK
Cells
Macr
op
hag
es/
Mo
no
cyte
s
Pla
tele
ts
Ery
thro
cyte
s
Ste
m C
ells
Den
dri
tic
Cells
En
do
thelial C
ells
Ep
ith
elial C
ells
Beck
man
Co
ult
er
Clo
ne
CD99 MIC2 gene product, E2 p p p
CD99R restricted CD99 p p
CD100 SEMA4D (semaphorin 4D) p Low p p p n n
CD101 V7, P126 Act n p n p n n p
CD102 ICAM-2 (intercellular adhesion molecule-2) p p n p Folli p
CD103 HML-1 (human mucosal lymphocytes antigen 1), integrin aE chain S n n n n n n n lCD104 integrin b4 chain; TSP-1180 n n n n n n n p p
CD105 endoglin n n n n S n n p p lCD106 VCAM-1 (vascular cell adhesion molecule-1), INCAM-110 n n n n S n n Folli Act lCD107a LAMP-1 Act Act Act Act Act Act n lCD107b LAMP-2 Act Act Act Act Act Act n
CD108 JMH human blood group antigen, Sema L, GPI-gp80 Low Low n n p
CD109 8A3, E123, platelet activation factor Act n n n n Act n S p S lCD110 TPO-R (thrombopoietin receptor), c-mlp n n n n n p n p n p p
CD111 PRR1, nectin1, Hve C1, PVRL1 n n S p p p S p p
CD112 PRR2, nectin2, Hve B, PVRL2 n S p p n S p p
CD113 PRR3 , nectin 3, PVRL3 p
CD114 G-CSFR, HG-CSFR, CSF3R n n p n p p n p p
CD115 M-CSFR, CSF-1R, c-fms n n n p n n p n
CD116 GM-CSF receptor a-subunit n n p n p n n p lCD117 c-kit, stem cell factor receptor (SCFR) n n n n n n n p n n lCD118 LIFR (leukemia inhibitory factor receptor) p
CD119 IFNγ receptor a-chain, IFNγRI p p p p p n p
CD120a TNF receptor type 1, TNFR p55 p p p p p n p p p lCD120b TNF receptor type 2, TNFR p75 p p p p p n p p p lCD121a IL-1 receptor type I p n n n n n n n p n
CD121b IL-1 receptor type II n p S p n n n S
CD122 IL-2Rb p p n p p n n n lCD123 IL-3Ra n S p p p p p lCD124 IL-4Ra Act Act n n p n n p n n p
CD125 IL-5Ra n S S n n n n n
CD126 IL-6Ra p p n n p n lCD127 IL-7Ra p n n p n n p n lCD128a IL-8Ra, CXCR1-> Reassigned CD181 see CD181
CD128b IL-8Rb, CXCR2 -> Reassigned CD182 see CD182
CD129 IL-9Ra p p
CD130 gp130 Low Act Low Low p n p n p
CD131 common b-chain n n p n p p
CD132 common γ-chain, IL-2Rγ p p p p p n
CD133 PROML1 (prominin-like 1) n n n n n n n p n p p
CD134 OX40, TNFRSF4 Act n n lCD135 FLT3, STK-1 n n n n n n n p n lCD136 RON, MSP-R (macrophage stimulating protein receptor) p p lCD137 4-1BB, ILA (induced by lymphocyte activation), TNFRSF9 Act Act n n p Folli p
CD138 Syndecan-1, heparan sulfate proteoglycan n p n n n n n p p p lCD139 - n p p n p Low n Folli
CD140a PDGF Ra (platelet-derived growth factor receptor a) n n n n n p n p
CD140b PDGF Rb (platelet-derived growth factor receptor b) n n n n n n n p
CD141 TM (thrombomodulin), fetomodulin, BDCA-3 n n p n p p n p p lCD142 Tissue factor, thromboplastin, coagulation factor III n n n n p n p p
CD143 ACE (angiotensin-converting enzyme), peptidyl dipeptidase A S n n n Act n n p p
CD144 VE-cadherin, cadherin-5 n n n n n n n n p n lCDw145 - n n n n n p p
CD146 MUC18, S-Endo, MCAM, Mel-CAM, A32 S / Act n n n n n n Folli p lCD147 EMMPRIN (extracellular metalloprotein inducer), M6, basigin p p p p p p p p
CD148 HPTP-h, DEP-1, p260 p p p p p p p n
CD149 Now CD47R Now CD47R
CD150 SLAM (signaling lymphocyte activation molecule), IPO-3 S S n n n n n p p
CD151 PETA-3 (platelet-endothelial tetra-span antigen), SFA-1, Tspan-24 n n n n p p n p p
CD152 CTLA-4 (cytotoxic T lymphocyte antigen) S / Act S / Act n n n n n lCD153 CD30 ligand, CD30L Act p Act n
CD154 CD40 ligand, CD40L, gp39, TRAP, T-BAM Act Act p Act n p n lCD155 PVR (polio virus receptor), nectin-like 5 p n n
CD156a ADAM8, MS2 p p
CD156b ADAM17, TACE, snake venom like protease CSVP p n p n p n n n n p n
CD156c ADAM10 p p p
CD157 BST-1, Mo5 S S p p p Folli p lCD158a KIR2DL1, p58.1 S S lCD158b1 KIR2DL2, p58.2 S S lCD158b2 KIR2DL3, p58.3 S S lCD158c KIR2DS6, KIRX, KIR3DP1 S S
CD158d KIR2DL4, KIR103AS S S
CD158e1 KIR3DL1, p70, NKBI S S lCD158e2 KIR3DS1, p70 S S lCD158f KIR2DL5 S S lCD158g KIR2DS5 S S
CD158h KIR2DS1, p50.1 S S lCD158i KIR2DS4, p50.3 S S lCD158j KIR2DS2, p50.2 S S lCD158k KIR3DL2, p140 S S
CD158z KIR3DL3, KIR3DL7, KIRC1, KIR44 S
CD159a NKG2A, KLRC1 S lCD159c NKG2C, KLRC2 p
CD160 BY55, NK1, NK28 p n p lCD161 NKR-P1A p n n p n n n n n lCD162 PSGL-1 p p p p n n p n
CD162R PEN5, PSGL1, SELPLG (Selectin P ligand) p
CD163 M130 n n n p n n n n n
CD164 MGC-24, MUC-24 Low Low n p n p p p
CD165 AD2, gp37 S / Low n p p n n p
CD166 ALCAM, KG-CAM Act n Act p p p lCD167a DDR1, trkE, trk6, RTK6, NTRK4, MCK10, cak, eddr1 Low p p
CD167b DDR2, TKT, MIG20a, NTRKR3, TYRO10
CD168 RHAMM (receptor for hyaluronan involved in migration and motility) S / Act Act p Low
CD169 SN (sialoadhesin), Siglec-1 p p
CD170 Siglec-5 n p n S p
CD171 N-CAM (neural cell adheion molecule), L1 S S p p p
CD172a SIRPa (signal regulatory protein a), SHPS-1 p p
CD172b SIRPb1 (signal regulatory protein b1) p p
CD172g SIRPb2 (signal regulatory protein b2), SIRPγ, p p
CD173 blood group H2 n p p p
CD174 Lewis Y blood group n S
CD175 Tn antigen p p n S p
CD175s Sialyl-Tn n p n p p p
CD176 TF (Thomsen-Friedenreich antigen) n p S p p
CD177 NB1, PRV1 (polycythemia vera rubra 1), HNA-2a S
CD178 Fas ligand, TNFSF6, APT1LG1, CD95L Act n p p n n n p p
CD179a Vpre-b, VPREB1 (pre lymphocyte gene 1), IGVPB
CD179b Ig Lambda 5, IGLL1
CD180 RP105, Bgp95 S p p lCD181 CXCR1, IL-8Ra, formerly CD128a S p Low p
CD182 CXCR2, IL-8Rb, formerly CD128b S p Low p
CD183 CXCR3, GPR9 (G protein-coupled receptor 9) Act p Act p
CD184 CXCR4, fusin, LESTR, NPY3R S p p p p p p lCD185 CXCR5, BLR1, MDR15 p p p p p p
CD186 CXCR6, BONZO, STRL13 Act
CD191 CCR1, CKR1 p p p S
CD192 CCR2, CKR2, MCP-1-R Act p p p p
CD193 CCR3, CKR3, Eosinophil eotaxin receptor p S / Low p p
CD194 CCR4 S S p p
CD195 CCR5, CKR5 S n n p n n n
CD196 CCR6, CKR6, LARC receptor S p n S n S lCD197 CCR7, EBI1, BLR2 S Act S lCDw198 CCR8, CKRL1, GPRCY6, TER1 S p
CDw199 CCR9, CMKBR9, D6, GPR-9-6 S
CD200 OX2, MRC Act Low n n n n n p Folli p lCD201 EPC R, CCCA, CCD41, bA42O4.2 p S
CD202b TIE2, TEK S p p
CD203c E-NPP3, NPP3, PDNP3, B10, PD-1b S lCD204 MSR (macrophage scavenger receptor), SRA p
CD205 DEC205, CLEC13B, gp200-MR6, Ly75 p p p p p
CD206 MMR (macrophage mannose receptor) p S p p lCD207 Langerin, Lag p lCD208 DC-LAMP ACT lCD209 DC-SIGN p p p lCD210a IL-10RA, IL10R1, CRFB4 p p n n p n
CDw210b IL-10RB, IL10R2, CRFB4 p p p p p
CD212 IL-12 receptor b1-chain p p n p n n
CD213a1 IL-13 receptor a1, NR4 p p p p
CD213a2 IL-13 receptor a2 p p p
CD215 IL-15RA p p n n n n
CD217 IL-17 receptor p p p p p p p p p
CD218a IL-18 receptor a p p p p p p
CD218b IL-18 receptor b p p p p p
CD220 Insulin receptor, INSR p p p p p p p p p
CD221 IGF1 receptor p p p p p p p p p
CD222 man-6p, IGF2R, CIMPR, M6P-R p p p p p p p p p
CD N° Alternative Name
T C
ells
B C
ells
Gra
nu
locy
tes
NK
Cells
Macr
op
hag
es/
Mo
no
cyte
s
Pla
tele
ts
Ery
thro
cyte
s
Ste
m C
ells
Den
dri
tic
Cells
En
do
thelial C
ells
Ep
ith
elial C
ells
Beck
man
Co
ult
er
Clo
ne
CD223 LAG-3 (Lymphocyte activation gene 3) Act n Act p n
CD224 GGT (γ-glutamyl transferase) p p p p p p
CD225 Leu13, interferon induced transmembrane protein 1 (IFITM1). p p p p p
CD226 DNAM-1, PTA-1 Act n Act Act Act n p n
CD227 MUC1, mucin 1, episialin, PUM, PEM, EMA, DF3, H23 Act p
CD228 Melanotransferrin (MT), p97 p p
CD229 Ly9, T-lymphocyte surface antigen p p n p n n n p p
CD230 Prion protein, PrPc p p p p p p p p p
CD231 TALLA-1, TM4SF2, A15, MXS1, CCG-B7
CD232 VESP R, PLXNC1, plexin C1 p p p p p
CD233 band 3, SLC4A1, AE1, Diego blood group, EPB3 n n n n n p n
CD234 Fy-glycoprotein, Duffy blood group antigen, DARC n n n n n p n p p
CD235a Glycophorin A, PAS-2 n n n n n p p n lCD235b Glycophorin B, PAS-3 p
CD236 Glycophorin C/D p
CD236R Glycophorin C p
CD238 Kell blood group antigen p
CD239 B-CAM, Lutheran glycoprotein p p p
CD240 Rh blood group system, Rh30CE p p
CD241 RhAG, Rh50 n n n n n n p n n
CD242 ICAM-4, LW blood group n n n n n n p p n
CD243 MDR-1 (multidrug resistance protein I), Pgp (P-glycoprotein) n n n n n n n p p p lCD244 2B4, NAIL, p38 S n S p p lCD245 p220/240 S / Low p p p p
CD246 ALK (anaplastic lymphoma kinase)
CD247 T-cell receptor z-chain , CD3z p p
CD248 TEM1, Endosialin, CD164L1 p
CD249 Aminopeptidase A p
CD252 OX40L, CD134L, TXGP1, TNFSF4 p p p
CD253 TRAIL, APO2L, TNFSF10 Act p p p
CD254 TRANCE, TNFSF11, RANKL Act
CD255 TWEAK, APO3L, DR3-L, TNFSF12 p p p p
CD256 APRIL, TNFSF13, TALL2 p
CD257 BLyS , BAFF, TALL1 , TNFSF13B p p
CD258 LIGHT, TNFSF14 S
CD261 TRAIL-R1, DR4, TNFRSF10A
CD262 TRAIL-R2, DR5, TNFRSF10B
CD263 TRAIL-R3, DcR1, TNFRSF10C p p p p p
CD264 TRAIL-R4, DcR2, TNFRSF10D, TRUNDD p p p p p n
CD265 TRANCE-R, RANK, TNFRSF11A, EOF, FEO, OFE, ODFR, PDB2 p p p p p n n p
CD266 TWEAK-R, TNFRSF12A, FN14 p
CD267 TACI, TNFRSF13B p
CD268 BAFFR, BR3 p p p p p n
CD269 BCMA, BCM, TNFRSF17
CD270 TNFRSF14, TR2, ATAR, HVEA, HVEM, LIGHTR p p S
CD271 NGFR (p75), LNGFR, NTR, TNFRSF16 Folli
CD272 BTLA (B and T lymphocyte attenuator) p p n p S
CD273 PD-L2, B7-DC, PDCD1LG2 Act Act
CD274 B7-H1, PD-L1, PDCD1LG1 p p p p p p lCD275 B7-H2, B7RP-1, ICOS-L, GL50 p p p n p p
CD276 B7-H3 Act Act Act Act Act
CD277 BT3.1, BTF5 p p p p p p
CD278 ICOS (inducible costimulator) Act lCD279 PD1, PDC1 Act Act Act lCD280 Endo180, TEM22, MRC2 p p p
CD281 TLR1 (TOLL-like receptor 1), TIL p p
CD282 TLR2 (TOLL-like receptor 2), TIL4 p p
CD283 TLR3 (TOLL-like receptor 3) p p n n n p
CD284 TLR4 (TOLL-like receptor 4) p
CD285 TLR5 (TOLL-like receptor 5), TIL3 p S
CD286 TLR6 (TOLL-like receptor 6) p p p
CD287 TLR7 (TOLL-like receptor 7) p S
CD288 TLR8 (TOLL-like receptor 8) p p p
CD289 TLR9 (TOLL-like receptor 9) p p p n p Plasm
CD290 TLR10 (TOLL-like receptor 10) p p p p
CD291 TLR11 (TOLL-like receptor 11)
CD292 BMPR1A, ALK-3 p
CDw293 BMPR1B, ALK-6 p
CD294 CRTH2, GPR44, PGRD2, DP2 S p lCD295 LEPR (leptin receptor), OBR, B219 p p p p p p p p p p
CD296 ART1 S p
CD297 ART4, Dombrock blood group Act p Low
CD298 Na/K-ATPase b3 subunit p p p p p p p p
CD299 DC-SIGN-2, DC-SIGNR, L-SIGN S
CD300a IRP60, CMRF35H9, IRC1, IRC2 S S S S S p lCD300c LIR, CMRF35A1 S S p p p
CD300e CMRF35L1 p p
CD301 MGL, CLECSF14, CLEC10A, HMGL p S
CD302 DCL1, BIMLEC, CLEC13A p p p
CD303 BDCA2, CLECSF11, DLEC, HECL Plasm
CD304 BDCA-4, neuropilin-1, VEGF165R S Plasm
CD305 LAIR1 (leucocyte-associated Ig-like receptor 1) p p p p p p
CD306 LAIR-2 (leucocyte-associated Ig-like receptor 2) p p p
CD307 IRTA2, FcRH5, BXMAS1 S
CD307a FCRL1, FCRH1, IFGP1, IRTA5 n p n n n n
CD307b FCRL2, FcRH2, IFGP4, IRTA4, SPAP1 n p n n n n
CD307c FCRL3, FcRH3, IFGP3, IRTA3, SPAP2 p p n n n n
CD307d FCRL4, FcRH4, IFGP2, IRTA1 n p n n n n
CD307e FCRL5 n p n n n n n
CD307f FCRL6 p
CD308 VEGFR1 (vascular endothelial growth factor receptor 1), Flt-1 p p
CD309 VEGFR2 (vascular endothelial growth factor receptor 2), KDR p p lCD310 VEGFR3 (vascular endothelial growth factor receptor 3), Flt-4 p
CD311 EMR1 p
CD312 EMR2 Act p p p
CD313 EMR3 p p
CD314 NKG2D p p p n lCD315 CD9P1, SMAP6, FPRP S Act
CD316 EWI-2, IgSF8, PGRL p p p
CD317 BST2 (bone marrow stromal cell antigen 2), HM1.24 p p p p p
CD318 CDCP-1 (CUB domain-containing protein 1), SIMA135 p
CD319 CRACC, SLAMF7 S Act p S
CD320 8D6A Folli
CD321 JAM-1 (junctional adhesion molecule-1), JAM-A, F-11R p p p p p p
CD322 JAM-2 S p p p
CD323 JAM-3, JAM-C, VE-JAM p p p p
CD324 E-Cadherin, cadherin 1, ECAD, CDHE, CDH1, uvomorulin p p p
CD325 N-Cadherin, Cadherin 2, NCAD, CDHM, CDH2 p p
CD326 Ep-CAM, EGP40 p
CD327 siglec6, OB-BP1, CD33L p Low
CD328 AIRM1, siglec7, p75 S Low p p lCD329 siglec9 S S p p p
CD330 siglec10 S S p S p
CD331 FGFR1 (fibroblast growth factor receptor 1), FLT2, FLG p p
CD332 FGFR2, KGFR (keratinocyte growth factor receptor), TK14, BEK p
CD333 FGFR3, JTK4 p
CD334 FGFR4, JTK2, TKF p
CD335 NKp46, NCR1 p lCD336 NKp44, NCR2 S Act lCD337 NKp30, NCR3 p lCD338 ABCG2, BCRP1 S S
CD339 Jagged-1, JAG1 p
CD340 HER2/neu, ERBB2 S p
CD344 Fz4, Frizzled-4 p p
CD349 Fz-9, Frizzled-9 p
CD350 Fz10, Frizzled-10 p
CD351 FCA/MR, Fc receptor, IgA, IgM, high affinity p p n n p Folli
CD352 SLAMF6, NTB-A, KAL1, Ly108 p p S p p lCD353 SLAMF8, BLAME, SBBI42 Act Act n n Act S
CD354 TREM1 (Triggering receptor expressed on myeloid 1) p p S
CD355 CRTAM (Cytotoxic and regulatory T-cell molecule) p p p n n
CD356 TNFRSF14, HVEM, HVEA, ATAR, TR2 S
CD357 TNFRSF18, GITR, AITR S / Act n p
CD358 TNFRSF21, DR6 p p n n p n
CD359 IL15RA p n n n n
CD360 IL21R, NILR p p p p p p
CD361 EV12B (Ecotropic viral integration site 2B) p p p p p n
CD362 Syndecan-2, SDC2, HFGP1 p p p n p n
CD363 S1PR1, EDG-1, CHEDG1 p p n p n n
CD365 TIM-1, HAVCR1, TIMD1 S / Act S p
CD366 TIM-3, HAVCR2, TIMD3 S
CD367 DCIR, CLECSF6, CLEC4A, DDB27 p S p p
CD368 CLEC6, MCL, CLECSF8, CLEC4D p S S
CD369 DECTIN-1, CLEC7A, CLECSF12 S p p
CD370 DNGR1, CLEC9A, HEEE9341, UNQ9341 S lCD371 CLL-1, MICL, CLEC12A, DCAL-2 p p p
References:
• PROW web site: http://www.ncbi.nlm.nih.gov/prow/• HCDM web site: http://www.hcdm.org• Leukocyte and Stromal Cell Molecules, The CD Markers, Zola, H., et al. Eds. Wiley-Liss
(2007)
• Leucocyte Typing: Bernard, A., et al. Eds., Springer-Verlag (1984)• Leucocyte Typing II: Reinherz,E.L., et al. Eds., Springer-Verlag (1986)• Leucocyte Typing III: McMichael, A.J., et al. Eds., Oxford University Press (1987)• Leucocyte Typing IV: Knapp, W., et al. Eds., Oxford University Press (1989)• Leucocyte Typing V: Schlossman, S.F., et al. Eds., Oxford University Press (1995)• Leucocyte Typing VI: Kishimoto, T., et al. Eds., Oxford University Press (1997)• Leucocyte Typing VII: Mason, D., et al. Eds., Oxford University Press (2002)
Content reflects information analyzed from the referenced publications.I Paris - France 1982
II Boston - USA 1984
III Oxford - UK 1987
IV Vienna - Austria 1989
V Boston - USA 1993
VI Kobe - Japan 1996
VII Harrogate - UK 2000
VIII Adelaide - Australia 2004
IX Barcelona - Spain 2010
X Wollongong - Australia 2014
Codes: : negative
Act : positive upon activation
Low : low expression
S : positive on a subset
S/Low : low expression on a subset
S/Act : subset of activated cells
: positive
: no data
l : clone available at Beckman Coulter Beckman Coulter and the stylized logo are trademarks of Beckman Coulter, Inc. and are registered in the USPTO.
FLOW-872PST11.15-A ©2015BeckmanCoulter,Inc.